Angerer, V, Schmid, Y, Franz, F, Gnann, H, Speer, J, Gnann, A, Helmecke, S, Buchwald, A, Brandt, S, Passie, T, Liechti, M and Auwärter, V (2023) Acute psychotropic, autonomic, and endocrine effects of 5,6-methylenedioxy-2-aminoindane (MDAI) compared with 3,4-methylenedioxymethamphetamine (MDMA) in human volunteers: A self-administration study. Drug Testing and Analysis. ISSN 1942-7603

Hutter, M, Broecker, S, Kneisel, S, Franz, F, Brandt, SD and Auwärter, V (2018) Metabolism of synthetic cannabinoid receptor agonists encountered in clinical casework: major in vivo phase I metabolites of JWH-007, JWH-019, JWH-203, JWH-307, UR-144, XLR-11, AM-2201, MAM-2201 and AM-694 in human urine using LC-MS/MS. Current Pharmaceutical Biotechnology. ISSN 1389-2010

Franz, F, Angerer, V, Brandt, SD, McLaughlin, G, Kavanagh, PV, Moosmann, B and Auwärter, V (2016) In vitro metabolism of the synthetic cannabinoid 3,5-AB-CHMFUPPYCA and its 5,3-regioisomer and investigation of their thermal stability. Drug Testing and Analysis. ISSN 1942-7611